SAMAD SAM 4
4 · QUEST DIAGNOSTICS INC · Filed Apr 24, 2026
Research Summary
AI-generated summary of this filing
Quest Diagnostics CFO Samad Sam Receives Award of 108 Shares
What Happened Samad Sam, Executive Vice President & Chief Financial Officer of Quest Diagnostics (DGX), was granted 108 restricted share units on April 20, 2026. The filing reports an acquisition value of $194.70 per share, totaling approximately $21,027. This transaction is an award/grant (not an open-market purchase or sale).
Key Details
- Transaction date: April 20, 2026; reported price: $194.70; total value: ~$21,027.
- Filing date: April 24, 2026 (Form 4 covering the April 20 transaction); filing appears timely.
- Shares owned after the transaction: Not disclosed in the Form 4.
- Footnotes: F1 indicates these are restricted share units (RSUs). F2 describes shares acquired via a dividend reinvestment plan that the filer elected to report early on this Form 4 (normally eligible for deferred reporting on Form 5).
- Transaction type code: A (award/grant).
Context RSU grants are a common form of executive compensation and typically vest over time; they are not the same as an immediate market purchase and do not by themselves indicate the insider is buying or selling for investment reasons. This filing is informational and factual—no inference about the CFO’s market view should be drawn from the award alone.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-04-20$194.70/sh+108$21,027→ 33,376 total
Footnotes (2)
- [F1]Represents an award of restricted share units.
- [F2]Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5. The reporting person has chosen to report such transaction early on this Form 4.